IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $12,664,000 | -31.8% | 400,000 | 0.0% | 0.22% | -43.7% |
| Q4 2020 | $18,560,000 | +40.9% | 400,000 | 0.0% | 0.40% | +24.4% |
| Q3 2020 | $13,168,000 | -4.1% | 400,000 | -20.0% | 0.32% | -16.7% |
| Q2 2020 | $13,725,000 | -38.9% | 500,000 | -33.3% | 0.38% | -59.5% |
| Q1 2020 | $22,451,000 | +62.2% | 750,000 | +50.0% | 0.95% | +77.4% |
| Q4 2019 | $13,840,000 | +8.6% | 500,000 | -28.6% | 0.54% | +4.7% |
| Q3 2019 | $12,740,000 | -25.8% | 700,000 | 0.0% | 0.51% | -26.4% |
| Q2 2019 | $17,164,000 | +261.0% | 700,000 | +40.0% | 0.69% | +257.7% |
| Q1 2019 | $4,755,000 | +7.5% | 500,000 | 0.0% | 0.19% | +18.3% |
| Q4 2018 | $4,425,000 | -43.8% | 500,000 | -28.6% | 0.16% | -20.0% |
| Q3 2018 | $7,875,000 | -12.1% | 700,000 | 0.0% | 0.20% | +7.9% |
| Q2 2018 | $8,960,000 | +15.3% | 700,000 | +52.2% | 0.19% | +95.9% |
| Q1 2018 | $7,774,000 | – | 460,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |